News S3-E35.4 – Liver Science At #ILC2022: Commercial Benefits From the New Liver Science Jul 10, 2022 S3-E35.3 – Liver Science At #ILC2022: Stellate Cells, Omics and Novel Receptor Targets Jul 10, 2022 S3-E35.2 – Liver Science At #ILC2022: The Interplay of Stellate Cell Dynamics and Hepatic Fibrosis Jul 9, 2022 S3-E35.1 – Liver Science at #ILC2022: Circadian Rhythm and Stellate Cells Jul 9, 2022 S3-E35 – #ILC2022 Look Back: Liver Science and Fibrosis Jul 7, 2022 S3-E32.3 – #ILC2022 Looking Back: NASH Is a Complex Disease Jul 5, 2022 S3-E34.4 – #ILC2022 looking back: Crystal Balling and The Semaglutide Trial Jul 4, 2022 S3-E33.2 – #ILC2022 Looking Back: Patient Engagement 2 — Patient Communication Jul 4, 2022 S3-E32.2 – #ILC2022 Looking Back: NAFLD and Quality-of-Life Jul 4, 2022 S3-E32.1 – #ILC2022 Looking Back: Patient Motivation and Systems Incentives Jul 4, 2022 S3-E34.3 – #ILC2022 Looking Back: Early Pemvidutide Results and a Little More on FIB-4 Jul 3, 2022 S3-E33.1 – #ILC2022 Looking Back: Patient Engagement 1 — Nurses and Touchy Topics Jul 3, 2022 « Older Entries Next Entries »
S3-E35.2 – Liver Science At #ILC2022: The Interplay of Stellate Cell Dynamics and Hepatic Fibrosis Jul 9, 2022